BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 12940471)

  • 1. Chronic endopeptidase inhibition in DOCA-salt hypertension: mechanism of cardiovascular protection.
    Newaz MA; Yousefipour Z; Hercule H; Truong L; Oyekan A
    Clin Exp Hypertens; 2003 Aug; 25(6):335-47. PubMed ID: 12940471
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2,3',4,5'-Tetramethoxystilbene prevents deoxycorticosterone-salt-induced hypertension: contribution of cytochrome P-450 1B1.
    Sahan-Firat S; Jennings BL; Yaghini FA; Song CY; Estes AM; Fang XR; Farjana N; Khan AI; Malik KU
    Am J Physiol Heart Circ Physiol; 2010 Dec; 299(6):H1891-901. PubMed ID: 20852048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morin attenuates blood pressure and oxidative stress in deoxycorticosterone acetate-salt hypertensive rats: a biochemical and histopathological evaluation.
    Prahalathan P; Kumar S; Raja B
    Metabolism; 2012 Aug; 61(8):1087-99. PubMed ID: 22386933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant angiotensin AT1 receptor antagonism and neprilysin inhibition produces omapatrilat-like antihypertensive effects without promoting tracheal plasma extravasation in the rat.
    Hegde LG; Yu C; Renner T; Thibodeaux H; Armstrong SR; Park T; Cheruvu M; Olsufka R; Sandvik ER; Lane CE; Budman J; Hill CM; Klein U; Hegde SS
    J Cardiovasc Pharmacol; 2011 Apr; 57(4):495-504. PubMed ID: 21297495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diosmin, a bioflavonoid reverses alterations in blood pressure, nitric oxide, lipid peroxides and antioxidant status in DOCA-salt induced hypertensive rats.
    Silambarasan T; Raja B
    Eur J Pharmacol; 2012 Mar; 679(1-3):81-9. PubMed ID: 22266490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. (-)-Epicatechin Reduces Blood Pressure and Improves Left Ventricular Function and Compliance in Deoxycorticosterone Acetate-Salt Hypertensive Rats.
    Jackson D; Connolly K; Batacan R; Ryan K; Vella R; Fenning A
    Molecules; 2018 Jun; 23(7):. PubMed ID: 29932135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CS-3150, a Novel Nonsteroidal Mineralocorticoid Receptor Antagonist, Shows Preventive and Therapeutic Effects On Renal Injury in Deoxycorticosterone Acetate/Salt-Induced Hypertensive Rats.
    Arai K; Morikawa Y; Ubukata N; Tsuruoka H; Homma T
    J Pharmacol Exp Ther; 2016 Sep; 358(3):548-57. PubMed ID: 27384074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epicatechin lowers blood pressure, restores endothelial function, and decreases oxidative stress and endothelin-1 and NADPH oxidase activity in DOCA-salt hypertension.
    Gómez-Guzmán M; Jiménez R; Sánchez M; Zarzuelo MJ; Galindo P; Quintela AM; López-Sepúlveda R; Romero M; Tamargo J; Vargas F; Pérez-Vizcaíno F; Duarte J
    Free Radic Biol Med; 2012 Jan; 52(1):70-9. PubMed ID: 22001745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grape seed proanthocyanidins prevent DOCA-salt hypertension-induced renal injury and its mechanisms in rats.
    Lan CZ; Ding L; Su YL; Guo K; Wang L; Kan HW; Ou YR; Gao S
    Food Funct; 2015 Jul; 6(7):2179-86. PubMed ID: 26011796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emblica officinalis exerts antihypertensive effect in a rat model of DOCA-salt-induced hypertension: role of (p) eNOS, NO and oxidative stress.
    Bhatia J; Tabassum F; Sharma AK; Bharti S; Golechha M; Joshi S; Sayeed Akhatar M; Srivastava AK; Arya DS
    Cardiovasc Toxicol; 2011 Sep; 11(3):272-9. PubMed ID: 21748534
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sodium butyrate ameliorates deoxycorticosterone acetate/salt-induced hypertension and renal damage by inhibiting the MR/SGK1 pathway.
    Wu C; Chen Z; Zhang L; Zhu Y; Deng M; Huang C; Liu Y; Zhu Q; Wang L
    Hypertens Res; 2021 Feb; 44(2):168-178. PubMed ID: 32908237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pentosan polysulfate preserves renal microvascular P2X1 receptor reactivity and autoregulatory behavior in DOCA-salt hypertensive rats.
    Guan Z; Singletary ST; Cha H; Van Beusecum JP; Cook AK; Pollock JS; Pollock DM; Inscho EW
    Am J Physiol Renal Physiol; 2016 Mar; 310(6):F456-65. PubMed ID: 26697978
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor Necrosis Factor Alpha Deficiency Improves Endothelial Function and Cardiovascular Injury in Deoxycorticosterone Acetate/Salt-Hypertensive Mice.
    Cai R; Hao Y; Liu YY; Huang L; Yao Y; Zhou MS
    Biomed Res Int; 2020; 2020():3921074. PubMed ID: 32190663
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced NO production rapidly aggravates renal function through the NF-κB/ET-1/ETA receptor pathway in DOCA-salt-induced hypertensive rats.
    Kimura K; Ohkita M; Koyama M; Matsumura Y
    Life Sci; 2012 Oct; 91(13-14):644-50. PubMed ID: 22569294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mild DOCA-salt hypertension: sympathetic system and role of renal nerves.
    Kandlikar SS; Fink GD
    Am J Physiol Heart Circ Physiol; 2011 May; 300(5):H1781-7. PubMed ID: 21357502
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The flavonoid morin restores blood pressure and lipid metabolism in DOCA-salt hypertensive rats.
    Prahalathan P; Saravanakumar M; Raja B
    Redox Rep; 2012; 17(4):167-75. PubMed ID: 22781105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fumarate exerted an antihypertensive effect and reduced kidney injury molecule (KIM)-1 expression in deoxycorticosterone acetate-salt hypertension.
    Edosuyi O; Choi M; Igbe I; Oyekan A
    Clin Exp Hypertens; 2021 Aug; 43(6):555-564. PubMed ID: 33879002
    [No Abstract]   [Full Text] [Related]  

  • 18. COX-2-independent activation of renal (pro)renin receptor contributes to DOCA-salt hypertension in rats.
    Wang F; Sun Y; Luo R; Lu X; Yang B; Yang T
    Am J Physiol Renal Physiol; 2020 Oct; 319(4):F647-F653. PubMed ID: 32799674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of cardiac, vascular, and renal dysfunction by non-quinazoline α1-adrenolytics in DOCA-salt hypertensive rats: a comparison with prazosin, a quinazoline-based α1-adrenoceptor antagonist.
    Kubacka M; Zadrożna M; Nowak B; Kotańska M; Filipek B; Waszkielewicz AM; Marona H; Mogilski S
    Hypertens Res; 2019 Aug; 42(8):1125-1141. PubMed ID: 30872813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal Inflammation in DOCA-Salt Hypertension.
    Banek CT; Gauthier MM; Van Helden DA; Fink GD; Osborn JW
    Hypertension; 2019 May; 73(5):1079-1086. PubMed ID: 30879356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.